Geno J. Germano - 14 May 2026 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Reporting relationship
Director
Issuer ticker
HRMY
Reported as of
14 May 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 May 2026, 21:51:38 UTC
Prior SEC filing
11 Mar 2026
Next SEC filing
22 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Christian Ulrich, Attorney-in-Fact

Key filing fact

Geno J. Germano filed Form 4 for Harmony Biosciences Holdings, Inc. (HRMY) on 18 May 2026.

Key facts

  • This page summarizes Geno J. Germano's Form 4 filing for Harmony Biosciences Holdings, Inc. (HRMY).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 18 May 2026, 21:51.

Change

  • Previous filing in this sequence was filed on 11 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001424383 Primary reporting owner

Germano Geno J

Relationship
Director
Address
C/O HARMONY BIOSCIENCES HOLDINGS, INC., 630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING
Signature
/s/ Christian Ulrich, Attorney-in-Fact
Signature date
18 May 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HRMY transaction Derivative

Stock Option

Award

Transaction value
Shares
+21,231
Change %
Price
$0.000000*
Shares after
21,231
Date
14 May 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
21,231
Exercise price
$30.76
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock option shall vest in 36 equal monthly installments beginning on June 14, 2026.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .